Sternocostoclavicular Hyperostosis

This is a rare condition where bone tissue grows abnormally between the collarbone and the upper ribs. It can cause pain and stiffness in the chest area. It's important to get the right diagnosis because it can sometimes be confused with other conditions.

Condition

What people with Sternocostoclavicular Hyperostosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Aleve (Naproxen) for Sternocostoclavicular Hyperostosis?

NameHow it went

About Sternocostoclavicular Hyperostosis

What It Is

Sternocostoclavicular hyperostosis (SCCH) is a rare, long-lasting inflammatory condition of the bones at the top of the chest, where the inner ends of the collarbones meet the breastbone and the upper ribs. The inflammation is sterile, meaning it is not caused by an active bacterial infection. Over time it makes the bone thicken and the ligaments around these joints harden, which is what "hyperostosis" refers to. The usual result is persistent pain and a firm, sometimes tender swelling at the base of the neck or front of the chest. The pain often spreads to the shoulder, and many people find it harder to lift, reach or carry, because the collarbone joints move with every shoulder movement. Some people also have inflammation in the spine or other joints. Doctors increasingly describe SCCH as the chest-wall form of chronic nonbacterial osteitis (CNO), a family of sterile bone-inflammation disorders. It overlaps with SAPHO syndrome, short for synovitis, acne, pustulosis, hyperostosis and osteitis, a broader condition that combines bone, joint and skin inflammation. In Japan, the form that comes with a skin rash on the palms and soles is often called pustulotic arthro-osteitis. These labels describe closely related presentations rather than clearly separate diseases.

Causes & Risk Factors

The cause is not known. Researchers think SCCH is an autoinflammatory disorder, meaning the body's built-in inflammatory responses become overactive without an outside infection to explain it. Bacteria have occasionally been found in affected bone, but cultures are almost always negative, and infection is not considered the main cause. SCCH usually starts in midlife, with an average onset in the late 30s, and it is more common in women. About half of people with SCCH also have palmoplantar pustulosis, a chronic skin condition with small, sterile pus-filled spots on the palms and soles, and a smaller number have severe acne or psoriasis. The skin and bone symptoms do not necessarily flare at the same time. Smoking is common among people with SCCH, especially those with palmoplantar pustulosis, and is thought to aggravate the inflammation. Throat or sinus infections such as tonsillitis have also been noted in many people with the condition and are being studied as possible triggers. These are associations, not proven causes.

How It's Diagnosed

There is no single test for SCCH, and diagnosis is often delayed, on average by about five years. Chest-wall and shoulder pain have many common, harmless causes, and the first tests ordered often look normal: plain X-rays miss the changes in a large share of people, and blood tests for inflammation, such as C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR), are raised in only about half. The key evidence comes from imaging. A nuclear bone scan, in which a small amount of radioactive tracer collects where bone is unusually active, almost always shows strong uptake at the collarbone and breastbone joints. A computed tomography (CT) scan shows the thickened bone and hardened ligaments in detail, and magnetic resonance imaging (MRI) can show active inflammation without radiation. International expert recommendations suggest MRI, or CT combined with a bone scan, as the first imaging for suspected adult CNO, and imaging of other areas when symptoms suggest they are involved, since other affected sites can change treatment choices. A clinician will also look for clues such as palmoplantar pustulosis and ask about back pain or other painful joints. Part of the work is ruling out look-alikes, including bone infection, tumors that spread to bone and Paget's disease of bone. A bone biopsy does not confirm SCCH itself; it is used when infection or cancer needs to be excluded, for example when a swelling looks atypical or grows quickly.

Treatment Options

There is no treatment standard based on large clinical trials, so care is tailored by a rheumatologist or bone specialist. The aims are to control pain, calm the inflammation, preserve shoulder movement and limit lasting bone changes. Nonsteroidal anti-inflammatory drugs (NSAIDs, the ibuprofen family of pain relievers) are the usual first step. They often ease pain but tend to give only partial relief, especially when the disease is widespread. When NSAIDs are not enough, expert recommendations favor intravenous bisphosphonates. These are bone-strengthening medicines, such as pamidronate, that slow the overactive bone turnover in SCCH. They are given as infusions at intervals of weeks to months. In published studies most people treated this way had a good response, though the studies were small and mostly uncontrolled, so the true size of the benefit is uncertain. A short, flu-like reaction after an infusion is common. Because bisphosphonates stay in bone for a long time and may affect a developing baby, anyone who is pregnant or may become pregnant should discuss this before starting infusions. The main alternative is a tumor necrosis factor (TNF) inhibitor, a biologic medicine given by injection or infusion that blocks a key inflammatory signal. It may suit people who also have significant joint or skin inflammation. A known trade-off is that some people develop new psoriasis-like skin rashes while taking it. TNF inhibitors also lower the body's defense against infections, so screening such as a tuberculosis test comes before starting. Other options, including methotrexate (an immune-suppressing medicine also used for inflammatory arthritis and psoriasis), corticosteroid injections into a painful joint, newer biologics and, rarely, surgery, are used in selected cases. Long courses of oral steroids are generally avoided because of side effects such as bone thinning in a long-term condition. Most treatments do little for the palmoplantar pustulosis, which usually needs its own care from a dermatologist.

What to Expect

SCCH is usually long term and tends to come and go, with flares of pain and swelling separated by quieter periods. Some people have only one or two episodes that settle, while others have years of activity, sometimes with new sites in the spine or other joints. Thickened bone that has already formed generally does not return to normal, which is one reason earlier diagnosis and treatment matter. Daily life is shaped mostly by pain and shoulder movement. Reaching overhead, carrying bags, sleeping on one side or some kinds of work can become difficult during flares. Research in people with SCCH shows that quality of life is often substantially affected, particularly when diagnosis was delayed, and that pain management and psychological support for coping can help. Follow-up usually means regular visits to review pain and function, with repeat imaging when the picture changes or a treatment decision depends on it. Treatment is often adjusted over time. Because smoking is linked to the inflammation, it is worth discussing stopping with your care team, although studies have not yet shown how much quitting changes the course.

When to Seek Help

Arrange an evaluation if pain or a firm swelling at the front of the chest, near the collarbone, lasts for weeks or keeps returning, especially if you also have pustules on your palms or soles, back pain, or difficulty moving your shoulder. If you are already diagnosed, contact your care team when flares become more frequent, pain stops responding to treatment, or treatment causes troublesome side effects or a new skin rash. Contact your care team promptly if a chest-wall swelling grows quickly or looks different from your usual flares. Rarely, swollen tissue or bone overgrowth can press on nearby veins, and blood clots in the main vein under the collarbone have been reported. New swelling of one arm or hand, or newly prominent veins over the shoulder or chest, should be checked by a clinician the same day.

Questions to Ask Your Doctor

  1. 1.What makes you confident this is sternocostoclavicular hyperostosis rather than an infection, a tumor or another bone condition?
  2. 2.Which imaging do I need now, and should we check my spine or other joints for involvement?
  3. 3.If anti-inflammatory pain relievers are not enough, how would we decide between bisphosphonate infusions and a TNF inhibitor?
  4. 4.How will we judge whether treatment is working, and how often will I need follow-up visits or scans?
  5. 5.What can I do day to day to protect my shoulder movement, and should I also see a dermatologist for my skin?

Last reviewed • Oct 2026

Educational content, not medical advice.